Allgens Medical Technology Co., Ltd. Changes to State of No Ultimate Controller

Image source: Allgens Medical's announcement regarding the change to having no actual controller

DentalGoodNews｜July 25, 2026 - Allgens Medical Technology Co., Ltd. (hereinafter referred to as "Allgens Medical Technology Co., Ltd.") issued an announcement, confirming that the company is currently in a state of no ultimate controller.

The change in control structure can be traced back to June 2025, when Cui Fuzhai, one of the original joint ultimate controllers, passed away due to illness. His shares were legally inherited by his heirs, Cui Han and Huang Wanlan, thereby loosening the original tripartite joint control foundation. In April 2017, the three parties jointly signed an "Acting in Concert Agreement," collectively controlling approximately 20.48% of the company's voting rights. The dissolution of this agreement marks the formal termination of this arrangement after nearly nine years.

The announcement shows that during Allgens Medical Technology Co., Ltd.'s first extraordinary general meeting of shareholders in 2026, the original concerted actors, Huang Wanlan, Cui Han, and Hu Gang, cast dissenting votes on the proposal to remove Huang Wanlan from her director position. Notably, prior to this, Cui Han and Hu Gang had also proposed to elect Hu Gang to the company's third board of directors. This proposal was opposed by seven directors, including Huang Wanlan, at the board level, with only Cui Han voting in favor, ultimately failing to be submitted for shareholder meeting review. The confrontation between the two factions thus became public. As the parties could no longer form a joint expression of intent, Huang Wanlan issued a written statement to the company on July 23, 2026, declaring the dissolution of the concerted action relationship, formally losing the original concerted action foundation.

According to the announcement, the shareholding ratios of Allgens Medical Technology Co., Ltd.'s top four major shareholders are currently close and relatively dispersed. Among them, Huang Wanlan controls a total disposable voting rights ratio of approximately 11.72%, Hu Gang holds 6.92%, and Cui Han holds 1.84%. No single shareholder can exert significant influence over shareholder meeting resolutions based on their voting rights, nor can they determine the election of a majority of board members. According to the "Administrative Measures for the Acquisition of Listed Companies," actual control of voting rights exceeding 30% constitutes the standard for control recognition; the original tripartite total of approximately 20.48% was already below this threshold, and each party's individual holdings are even further below.

Allgens Medical Technology Co., Ltd. stated that the change to a state of no ultimate controller will not have a significant adverse impact on the company's daily operations, financial condition, or sustainable operational capabilities. The company's corporate governance structure is sound and will continue to maintain independence in business, assets, and personnel.

According to previous reports from DENTALGOODNEWS (Leading Dental Industry Media, DGN), Allgens Medical Technology Co., Ltd. recently corrected data in its 2025 annual report, revising the gross profit margin of dental implants from a decline to an increase, primarily due to information verification errors.